Other direct [33,47,48,49] and indirect [45,50,51] AMPK activators have already demonstrated their capacity to protect the vascular barrier in in vivo models of sepsis, and some are even associated with anti-inflammatory effects [49,50,51] and improved survival [49]. The gene discussed is PRKAA1; the disease is Sepsis.